Patents by Inventor Stéphane Emiliani

Stéphane Emiliani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions
    Patent number: 8197821
    Abstract: The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides, fragments of the polypeptides, antibodies to the complexes, Selected Interacting Domains (SID®) which are identified due to the protein-protein interactions, methods for screening drugs for agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: June 12, 2012
    Assignee: Laboratoire Biodim
    Inventors: Pierre Legrain, Jean-Christophe Rain, Richard Benarous, Stéphane Emiliani, Clarissa Berlioz-torrent, Guillaume Blot
  • NOVEL SUBSTITUTED ARYL DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES AS ANTI-HIV AGENTS
    Publication number: 20120022054
    Abstract: The present invention concerns novel substituted aryl derivatives, their process of preparation and their use for inhibiting virus replication and for treating viral diseases or disorders such as HIV and/or HCV infection.
    Type: Application
    Filed: December 10, 2009
    Publication date: January 26, 2012
    Applicant: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Sabine Barbey-Treve, Jean-Marc Paris, Sebastien Berrut, Clarisse Berlioz-Torrent, Stephane Emiliani
  • Human immunodeficiency virus integrase-LEDGF p75 isoform protein-protein interactions
    Patent number: 7763254
    Abstract: The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides, fragments of the polypeptides, antibodies to the complexes, Selected Interacting Domains (SID®) which are identified due to the protein-protein interactions, methods for screening drugs for agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: July 27, 2010
    Assignee: Cellvir
    Inventors: Pierre Legrain, Jean-Christophe Rain, Richard Benarous, Stéphane Emiliani, Clarissa Berlioz-torrent, Guillaume Blot
  • Protein-protein interactions in human immunodeficiency virus
    Publication number: 20090004719
    Abstract: The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides, fragments of the polypeptides, antibodies to the complexes, Selected Interacting Domains (SID®) which are identified due to the protein-protein interactions, methods for screening drugs for agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.
    Type: Application
    Filed: February 25, 2008
    Publication date: January 1, 2009
    Applicant: Cellvir
    Inventors: Pierre Legrain, Jean-Christophe Rain, Richard Benarous, Stephane Emiliani, Clarissa Berlioz-torrent, Guillaume Blot
  • Protein-protein interactions in human immunodeficiency virus
    Publication number: 20060034860
    Abstract: The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides, fragments of the polypeptides, antibodies to the complexes, selected Interacting Domains (SID®) which are identified due to the protein-protein interactions, methods for screening drugs of agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.
    Type: Application
    Filed: May 26, 2004
    Publication date: February 16, 2006
    Applicant: Hybrigenics
    Inventors: Pierre Legrain, Jean-Christophe Rain, Richard Benarous, Stephane Emiliani, Clarissa Berlioz-torrent, Guillaume Blot